Acid-Fast bacilli smear and culture are two separate tests performed together to test for tuberculosis. It refers to the microscopic examination of a fluorochrome stain of a clinical specimen. The Acid-Bacilli is the inoculation of a clinical specimen on a mycobacteria growth indicator and a Lowenstein-Jensen (L-J) media slant. Tuberculosis is a serious health problem in many countries globally. It is also prevalent in countries that have preventive measures set up to avoid the disease in the community. Tuberculosis can occur in any anatomical site and thus, specimens other than the sputum such as urine, cerebrospinal fluid, pleural fluid, pus or biopsy specimens are submitted for Acid-Fast Bacillus test. Two procedures are most commonly used for acid-fast staining: Carbolfuschin method (includes Zeil-Neelson and Kinyoun Methods), which come under direct microscopy and the Flurochrome procedure that uses auramine-O or auramine-rhodamine dyes (Fluorescent microscopy). In the case of pulmonary tuberculosis (TB), positive results of acid-fast bacillus test convert to negative within three months of effective therapy. The disappearance of acid-fast bacilli from sputum smears is used to access the response to therapy. Further, physicians might make inappropriate management decisions by misinterpreting the positive smear results.
Drivers and Restraints for Acid-Fast Bacillus Test market
Tuberculosis, being one of the deadliest diseases, infects one-fourth of the world’s population. The increasing prevalence of tuberculosis globally is one of the leading factors that drives the acid-fast bacillus test market. However, the reduction of smear sensitivity is further reduced in patients with extra-pulmonary TB, being relatively insensitive.
Geographically, the global market for acid-fast bacillus test can be segmented into the following regions – North America, Latin America, Europe, Asia Pacific, Japan and Middle-East & Africa. Asia Pacific leads the global acid-fast bacillus testing market due to the high number of TB cases. Increasing healthcare expenditure and out of pocket expenditures in Asia Pacific are factors responsible for the growth of the Asia Pacific Market. Latin America and Middle-East and Africa are expected to follow Asia Pacific, owing to the prevalence of tuberculosis in these regions.
Some of the key players in the acid-fast bacillus test market are Azer Scientific, Statlab Medical Products, Becton-dickinson, ARUP Laboratories, Thermofisher Scientific, Vita Bee Health, Bio Lab Diagnostics Private Limited and Drucker Diagnostics. Key stakeholders in the acid-fast bacillus test market are manufacturers, distributors, wholesalers and subcomponent manufacturers.
The global market for acid-fast bacillus test can be segmented on the following parameters:
By End User
Key Data Points Covered in Report:
PMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.
Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.
Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.
Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.
On the other hand, we also analyse various companies annual reports_bk_01_01_2020, investor presentations, SEC filings, 10k reports_bk_01_01_2020 and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.
Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.